Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Short Interest Up 8.1% in November

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) was the target of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 14,700 shares, an increase of 8.1% from the October 31st total of 13,600 shares. Approximately 0.5% of the company’s stock are sold short. Based on an average daily trading volume, of 17,900 shares, the days-to-cover ratio is currently 0.8 days.

Institutional Investors Weigh In On Cryo-Cell International

An institutional investor recently raised its position in Cryo-Cell International stock. Geode Capital Management LLC grew its stake in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) by 68.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 39,860 shares of the company’s stock after purchasing an additional 16,203 shares during the period. Geode Capital Management LLC owned approximately 0.49% of Cryo-Cell International worth $254,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 10.44% of the stock is currently owned by hedge funds and other institutional investors.

Cryo-Cell International Trading Up 0.4 %

Shares of CCEL opened at $8.58 on Wednesday. The stock has a market capitalization of $69.11 million, a PE ratio of -8.09 and a beta of 0.49. Cryo-Cell International has a 52 week low of $4.47 and a 52 week high of $9.50.

Cryo-Cell International (NYSEAMERICAN:CCEL) last announced its earnings results on Tuesday, October 15th. The company reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.11. Cryo-Cell International had a negative return on equity of 42.06% and a negative net margin of 28.03%. The business had revenue of $8.07 million during the quarter.

Cryo-Cell International Announces Dividend

The business also recently declared a — dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a $0.25 dividend. The ex-dividend date of this dividend was Friday, November 15th. Cryo-Cell International’s dividend payout ratio (DPR) is presently -94.34%.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.